Study data demonstrate large step forward for this patient population
January 2023
A retrospective analysis presents unique results for AML treatment.
Significant study results may help inform clinical practice strategies.
Developments may soon impact clinical practice in hematology and oncology.
In this special January issue covering ASH and SABCS, we have divided the publication by conference.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Grants Interchangeability Designation to Denosumab Biosimilars Stoboclo and Osenvelt
2
Denosumab Biosimilars Conexxence and Bomyntra Receive Interchangeability Designation
3
Improving RSV Vaccine Coverage Could Prevent Thousands of Severe Cases in Older Adults
4
Recognizing Immunizing Pharmacists in the Community
5
